Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

OPHTHALMOLOGICAL INSTITUTE   OPHTALMOLOGICAL RESEARCH FOUNDATION   UNIVERSITY INSTITUTE   FERNÁNDEZ-VEGA FOUNDATION  Do we call you?
Welcome to MedicalPress a Premium Medical Theme
Title Image
You are in:  / Home  /  investigation   /  Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC)
LASTEST ACTIVITIES

 

RESEARCHER:

Dr. Álvaro Fernández-Vega Sanz

 ACTIVO 

 

Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC)


INDICATION: Patients with polypoid choroidal vasculopathy
TREATMENT: Aflibercept
PROMOTOR: AIBILI